Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004098426> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2004098426 endingPage "263" @default.
- W2004098426 startingPage "259" @default.
- W2004098426 abstract "Tiagabine (Gabitril) is a GABA uptake inhibitor recently introduced in the United States as an adjunctive treatment for partial complex seizures. Three published studies have addressed the use of tiagabine for bipolar disorder (BPD); two described positive results and one negative results. We assessed the efficacy of add-on tiagabine in a larger sample of adult BPD outpatients.Twenty-two adult outpatients with DSM-IV diagnosed BPD of some type who were considered unsatisfactory responders to standard medications for BPD were treated in an open fashion with adjunctive tiagabine in a low-dose range. After baseline demographic data and mood state at the time of entry were documented, each patient was monitored clinically for at least 6 months while the dose of tiagabine was adjusted according to the patient's clinical status. The subjects were rated using the clinical global impression-bipolar version scale (CGI-BP).After 6 months, eight (36%) of the patients were responders to tiagabine by CGI-BP rating. The dose range of tiagabine for responders was 1-8 mg per day. All 14 nonresponders had to discontinue tiagabine because of unacceptable but reversible side effects; one nonresponder experienced breakthrough absence seizures.This study was performed in a nonrandom, open naturalistic clinical setting. The sample size was small.Low-dose tiagabine appears to have mood-stabilizing and antimanic properties as an add-on medication for some adult outpatients who have BPD refractory to standard medications. Tiagabine appears to be safe for most adult BPD outpatients. The results of this preliminary open study await confirmation by double-blind controlled studies." @default.
- W2004098426 created "2016-06-24" @default.
- W2004098426 creator A5043373347 @default.
- W2004098426 creator A5074382476 @default.
- W2004098426 creator A5080287461 @default.
- W2004098426 date "2002-09-01" @default.
- W2004098426 modified "2023-10-16" @default.
- W2004098426 title "An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients" @default.
- W2004098426 cites W1968691427 @default.
- W2004098426 cites W1971815377 @default.
- W2004098426 cites W1974585730 @default.
- W2004098426 cites W1997253011 @default.
- W2004098426 cites W1999692103 @default.
- W2004098426 cites W2030034545 @default.
- W2004098426 cites W2035495751 @default.
- W2004098426 cites W2058120764 @default.
- W2004098426 cites W2396649693 @default.
- W2004098426 cites W4254882859 @default.
- W2004098426 cites W4254976833 @default.
- W2004098426 cites W4299498581 @default.
- W2004098426 doi "https://doi.org/10.1016/s0165-0327(01)00407-4" @default.
- W2004098426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12167526" @default.
- W2004098426 hasPublicationYear "2002" @default.
- W2004098426 type Work @default.
- W2004098426 sameAs 2004098426 @default.
- W2004098426 citedByCount "28" @default.
- W2004098426 countsByYear W20040984262012 @default.
- W2004098426 crossrefType "journal-article" @default.
- W2004098426 hasAuthorship W2004098426A5043373347 @default.
- W2004098426 hasAuthorship W2004098426A5074382476 @default.
- W2004098426 hasAuthorship W2004098426A5080287461 @default.
- W2004098426 hasConcept C118552586 @default.
- W2004098426 hasConcept C121332964 @default.
- W2004098426 hasConcept C126322002 @default.
- W2004098426 hasConcept C142424586 @default.
- W2004098426 hasConcept C15744967 @default.
- W2004098426 hasConcept C2775858608 @default.
- W2004098426 hasConcept C2776174506 @default.
- W2004098426 hasConcept C2776749334 @default.
- W2004098426 hasConcept C2778186239 @default.
- W2004098426 hasConcept C2780733359 @default.
- W2004098426 hasConcept C3018162438 @default.
- W2004098426 hasConcept C42219234 @default.
- W2004098426 hasConcept C71924100 @default.
- W2004098426 hasConcept C87355193 @default.
- W2004098426 hasConceptScore W2004098426C118552586 @default.
- W2004098426 hasConceptScore W2004098426C121332964 @default.
- W2004098426 hasConceptScore W2004098426C126322002 @default.
- W2004098426 hasConceptScore W2004098426C142424586 @default.
- W2004098426 hasConceptScore W2004098426C15744967 @default.
- W2004098426 hasConceptScore W2004098426C2775858608 @default.
- W2004098426 hasConceptScore W2004098426C2776174506 @default.
- W2004098426 hasConceptScore W2004098426C2776749334 @default.
- W2004098426 hasConceptScore W2004098426C2778186239 @default.
- W2004098426 hasConceptScore W2004098426C2780733359 @default.
- W2004098426 hasConceptScore W2004098426C3018162438 @default.
- W2004098426 hasConceptScore W2004098426C42219234 @default.
- W2004098426 hasConceptScore W2004098426C71924100 @default.
- W2004098426 hasConceptScore W2004098426C87355193 @default.
- W2004098426 hasIssue "1-3" @default.
- W2004098426 hasLocation W20040984261 @default.
- W2004098426 hasLocation W20040984262 @default.
- W2004098426 hasOpenAccess W2004098426 @default.
- W2004098426 hasPrimaryLocation W20040984261 @default.
- W2004098426 hasRelatedWork W1976130667 @default.
- W2004098426 hasRelatedWork W2013853917 @default.
- W2004098426 hasRelatedWork W2053294546 @default.
- W2004098426 hasRelatedWork W2074145368 @default.
- W2004098426 hasRelatedWork W2110167505 @default.
- W2004098426 hasRelatedWork W2748952813 @default.
- W2004098426 hasRelatedWork W2774064966 @default.
- W2004098426 hasRelatedWork W2793984419 @default.
- W2004098426 hasRelatedWork W2914819941 @default.
- W2004098426 hasRelatedWork W2985476322 @default.
- W2004098426 hasVolume "71" @default.
- W2004098426 isParatext "false" @default.
- W2004098426 isRetracted "false" @default.
- W2004098426 magId "2004098426" @default.
- W2004098426 workType "article" @default.